James Bates

Consultant

Escritórios: United Kingdom

Email: james.bates@technopolis-group.com

James Bates is a consultant in the Health and Life Sciences team at Technopolis Group. Through current projects, and prior work in the academic and NGO sectors, he has utilised a range of research methodologies including interviews, surveys, data analysis, case studies, literature reviews, network analysis, and bibliometric analysis. 

James is currently a team member in the impact and process evaluations of the UK Vaccine Network and UKRI’s Cross-Research Council Responsive Mode Pilot scheme. He is also supporting multiple European projects including the targeted evaluation of the EU Medical Device and In-vitro Diagnostics Regulations, and the study in the context of the Critical Medicines Act seeking legislative support options for reducing global pharmaceutical supply chain vulnerabilities for Europe’s Union list of Critical Medicines.  

Prior to joining Technopolis, James contributed to academic research of translational drug discovery at the Francis Crick Institute, and comparing policy responses relating to diagnostic testing internationally in response to the COVID-19 pandemic. During the pandemic he also supported the UK’s COVID-19 response by processing diagnostic PCR tests in an NHS laboratory. James subsequently worked closely with the Foundation for Innovative New Diagnostics (FIND) as a regulatory affairs consultant, taking part in projects supporting improved access to diagnostics in LMICs, as well as market landscaping activities and regulatory and procurement strategies.  

James received a Distinction in Science and Technology Policy (MSc) from the Science Policy Research Unit (SPRU) at the University of Sussex. His dissertation analysed how interdisciplinary research is supported in the UK’s biomedical research funding landscape. Before his MSc, James completed an undergraduate degree in Biological Sciences, also at the University of Sussex, informing on a range of biomedical topics across developmental biology, neuroscience, and cancer research.